Posted on 09/28/2022 9:19:25 PM PDT by ConservativeMind
In an analysis of outpatient data from over 5 million adults, hemoglobin level measured < 10 g/dl in more than 20% with advanced kidney disease, but less than 4% were treated with erythpoiesis-stimulating agents, and iron testing was infrequent.
Anemia, a common complication of chronic kidney disease, is associated with adverse outcomes. Unfortunately, the use of erythropoiesis-stimulating agents (ESAs) to target a normal hemoglobin level has been associated with increased cardiovascular risk. This large study of over 5 million patients sought to describe the burden and risk factors associated with anemia by estimated glomerular filtration rate (eGFR) level.
In a study, researchers found that severe anemia was common and strongly associated with lower eGFR and multiple adverse outcomes. ESA use was rare.
Although iron studies were checked infrequently, low iron test results were common in those tested. This highlights the need for increased testing of iron studies in patients with anemia, as iron supplementation is an effective and low-risk intervention.
(Excerpt) Read more at medicalxpress.com ...
It’s easy to treat.
Note that 60% of men and 81% of women with kidney issues had low iron (anemia), as referenced in the graphic in the article.
If you have kidney disease, you probably are in the group with anemia.
Disclaimer: Opinions posted on Free Republic are those of the individual posters and do not necessarily represent the opinion of Free Republic or its management. All materials posted herein are protected by copyright law and the exemption for fair use of copyrighted works.